Medicine

The Corpus Callosum

Category archives for Medicine

The new drug is called iloperidone; the brand name in the USA will be Fanapt.  It is yet another antipsychotic that blocks D2 and 5HT2 receptors.  Although there is no universally accepted way of classifying drugs into families, it will be referred to as an atypical or second-generation antipsychotic.  This designation will indicate a loose…

Tamiflu Dosing Errors in Kids

Practitioners are warned that it is astonishingly easy to make dosing errors with the oral suspension of Tamiflu (oseltamivir).  This is a product that is mostly given to kids, although it could be used for adults who have difficulty swallowing, or for anyone if there is a shortage of the capsules. The reason: usually, doctors…

Rethinking Alzheimer’s Disease

A recent report refers to the increasing number of Alzheimer patient an “emergency.”  Yet, despite an enormous amount of research, and a handful of drugs, we are not particularly close to having a robust intervention for this condition. Perhaps the reason is that we have been looking in the wrong place.  Traditionally, brain disease tend…

The SEIU website makes an astonishing claim: But, in DC and nine other states, including Arkansas, Idaho, Mississippi, North Carolina, North Dakota, Oklahoma, South Carolina, South Dakota, and Wyoming, insurance companies have gone too far, claiming that “domestic violence victim” is also a pre-existing condition. Words cannot describe the sheer inhumanity of this claim. It…

Pfizer Fine in Perspective

The odd thing about the Pfizer story is that it is old news.  Fierce Pharma wrote about it on 26 January 2009, and Neuron Culture posted about it, on 27 January 2009.  Yet it just appeared in the New York Times: Pfizer Pays $2.3 Billion to Settle Marketing Case By GARDINER HARRIS WASHINGTON — The…

The health care reform process is getting extremely ugly.  Healthcare insurers get upper hand Obama’s overhaul fight is being won by the industry, experts say. The end result may be a financial ‘bonanza.’ LA Times  By Tom Hamburger and Kim Geiger August 24, 2009 This Isn’t Reform, It’s Robbery Truthdig By Chris Hedges Aug 23,…

Fatigue

I haven’t been a good blog-citizen lately.  And no, it is not because of fatigue.  Anyway, I’ve going to try to get back to looking at other people’s blogs more, and not just here at ScienceBlogs.  Dr. Serani kindly pointed out an article on common causes of fatigue.  Sleep disorders, thyroid problems, diabetes, depression, and…

Why DSM-V Doesn’t Worry Me

A friend sent me a link to an article about the upcoming fifth edition of the American Psychiatric Association’s Diagnostic and Statistical Manual.  The article speaks of flaws in the process, and warning of dire “unintended consequences.” A Warning Sign on the Road to DSM-V: Beware of Its Unintended Consequences Allen Frances, MD June 26,…

Comparative Effectiveness Research (CER) has been controversial, as noted in the Washington Post.  Admittedly, most of the controversy has been contrived.  Fortunately, the process is moving forward; there is no meaningful opposition at this point. A good summary of the objections of this was posted by Hilzoy at Political Animal.  I’ll deal with the objections…

It was the second-most-blogged article on the NYT when I got up this morning; now, it is the first-most-blogged.  It is the article that reports on a survey that shows 72% support for a government-run health insurance program.  The program would be similar to Medicare, but would be available to persons under 65 and not…